Rote William E.'s Form 4 filing
Travere Therapeutics, Inc. (TVTX) · filed Sep 17, 2026
- Accession no.
- 0001698262-26-000005
- Filed
- Sep 17, 2026, 9:35 PM ET
- Trade date
- Sep 15-16, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 11 non-derivative transactions and 5 derivative transactions. Open-market sales total $13.1M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rote William E.CIK 0001698262 | Officer (Chief Research Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Common Stock | MOption exerciseAcquired | +39,000 | $25.25 | +$984,750 | 154,745 | Direct | |
| Sep 15, 2026 | Common Stock | MOption exerciseAcquired | +39,650 | $17.96 | +$712,114 | 194,395 | Direct | |
| Sep 15, 2026 | Common Stock | SSaleDisposed | −63,907 | $61.99 | −$3,961,850.56 | 130,488 | Direct | |
| Sep 15, 2026 | Common Stock | SSaleDisposed | −29,021 | $62.66 | −$1,818,316.56 | 101,467 | Direct | |
| Sep 15, 2026 | Common Stock | SSaleDisposed | −3,000 | $63.65 | −$190,952.4 | 98,467 | Direct | |
| Sep 15, 2026 | Common Stock | SSaleDisposed | −270 | $65.31 | −$17,633.7 | 98,197 | Direct | |
| Sep 16, 2026 | Common Stock | MOption exerciseAcquired | +350 | $17.96 | +$6,286 | 98,547 | Direct | |
| Sep 16, 2026 | Common Stock | MOption exerciseAcquired | +55,000 | $15.46 | +$850,300 | 153,547 | Direct | |
| Sep 16, 2026 | Common Stock | MOption exerciseAcquired | +57,500 | $26.88 | +$1,545,600 | 211,047 | Direct | |
| Sep 16, 2026 | Common Stock | SSaleDisposed | −65,104 | $63.12 | −$4,109,397.03 | 145,943 | Direct | |
| Sep 16, 2026 | Common Stock | SSaleDisposed | −47,746 | $63.61 | −$3,037,247.2 | 98,197 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Common Stock | MOption exerciseDisposed | −39,000 | $0.00 | $0 | 0 | Direct | |
| Sep 15, 2026 | Common Stock | MOption exerciseDisposed | −39,650 | $0.00 | $0 | 350 | Direct | |
| Sep 16, 2026 | Common Stock | MOption exerciseDisposed | −350 | $0.00 | $0 | 0 | Direct | |
| Sep 16, 2026 | Common Stock | MOption exerciseDisposed | −55,000 | $0.00 | $0 | 0 | Direct | |
| Sep 16, 2026 | Common Stock | MOption exerciseDisposed | −57,500 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.